While ZFHX3 has been implicated in the pathophysiology of obesity, SMARCA4 has been shown to regulate cholesterol levels, suggesting that the methylation of both genes could be essential biomarkers of myocardial infarction risk [131,132]. This evidence concerns the gene SMARCA4 and myocardial infarction.